Predicting factors associated with prolonged intensive care unit stay of patients with COVID-19
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background Predicting the length of stay (LOS) for coronavirus disease 2019 (COVID-19) patients in the intensive care unit (ICU) is essential for efficient use of ICU resources. We analyzed the clinical characteristics of patients with severe COVID-19 based on their clinical care and determined the predictive factors associated with prolonged LOS. Methods We included 96 COVID-19 patients who received oxygen therapy at a high-flow nasal cannula level or above after ICU admission during March 2021 to February 2022. The demographic characteristics at the time of ICU admission and results of severity analysis (Sequential Organ Failure Assessment [SOFA], Acute Physiology and Chronic Health Evaluation [APACHE] II), blood tests, and ICU treatments were analyzed using a logistic regression model. Additionally, blood tests (C-reactive protein, D-dimer, and the PaO2 to FiO2 ratio [P/F ratio]) were performed on days 3 and 5 of ICU admission to identify factors associated with prolonged LOS. Results Univariable analyses showed statistically significant results for SOFA score at the time of ICU admission, C-reactive protein level, high-dose steroids, mechanical ventilation (MV) care, continuous renal replacement therapy, extracorporeal membrane oxygenation, and prone position. Multivariable analysis showed that MV care and P/F ratio on hospital day 5 were independent factors for prolonged ICU LOS. For D-dimer, no significant variation was observed at admission; however, after days 3 and 5 days of admission, significant between-group variation was detected. Conclusions MV care and P/F ratio on hospital day 5 are independent factors that can predict prolonged LOS for COVID-19 patients.
Abstract
Background Predicting the length of stay (LOS) for coronavirus disease 2019 (COVID-19) patients in the intensive care unit (ICU) is essential for efficient use of ICU resources. We analyzed the clinical characteristics of patients with severe COVID-19 based on their clinical care and determined the predictive factors associated with prolonged LOS. Methods We included 96 COVID-19 patients who received oxygen therapy at a high-flow nasal cannula level or above after ICU admission during March 2021 to February 2022. The demographic characteristics at the time of ICU admission and results of severity analysis (Sequential Organ Failure Assessment [SOFA], Acute Physiology and Chronic Health Evaluation [APACHE] II), blood tests, and ICU treatments were analyzed using a logistic regression model. Additionally, blood tests (C-reactive protein, D-dimer, and the PaO2 to FiO2 ratio [P/F ratio]) were performed on days 3 and 5 of ICU admission to identify factors associated with prolonged LOS. Results Univariable analyses showed statistically significant results for SOFA score at the time of ICU admission, C-reactive protein level, high-dose steroids, mechanical ventilation (MV) care, continuous renal replacement therapy, extracorporeal membrane oxygenation, and prone position. Multivariable analysis showed that MV care and P/F ratio on hospital day 5 were independent factors for prolonged ICU LOS. For D-dimer, no significant variation was observed at admission; however, after days 3 and 5 days of admission, significant between-group variation was detected. Conclusions MV care and P/F ratio on hospital day 5 are independent factors that can predict prolonged LOS for COVID-19 patients.
참고문헌 (29)
- Choi JY, "COVID-19 in South Korea", Postgrad Med J, 96, pp.399~402 (2020)
- Bouadma L, "Severe SARS-CoV-2 infections : practical considerations and management strategy for intensivists", Intensive Care Med, 46, pp.579~582 (2020)
- Chen J, "Clinical progression of patients with COVID-19 in Shanghai, China", J Infect, 80, pp.e1~6 (2020)
- Duggal A, "Global variability in reported mortality for critical illness during the 2009-10 influenza A(H1N1) pandemic: a systematic review and meta-regression to guide reporting of outcomes during disease outbreaks", PLoS One, 11, pp.e0155044~ (2016)
- Elhadi M, "Concerns for low-resource countries, with under-prepared intensive care units, facing the COVID-19 pandemic", Infect Dis Health, 25, pp.227~232 (2020)
- Lai CC, "Global epidemiology of coronavirus disease 2019(COVID-19) : disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status", Int J Antimicrob Agents, 55, pp.105946~ (2020)
- Bravata DM, "Association of intensive care unit patient load and demand with mortality rates in us department of veterans affairs hospitals during the COVID-19 pandemic", JAMA Netw Open, 4, pp.e2034266~ (2021)
- Wilde H, "The association between mechanical ventilator compatible bed occupancy and mortality risk in intensive care patients with COVID-19 : a national retrospective cohort study", BMC Med, 19, pp.213~ (2021)
- Kim JH, "How South Korea responded to the COVID-19 outbreak in Daegu", NEJM Catal Innov Care Deliv, 1, pp.1~14 (2020)
- Sen-Crowe B, "A closer look into global hospital beds capacity and resource shortages during the COVID-19 pandemic", J Surg Res, 260, pp.56~63 (2021)
- Jain V, "Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission : a systematic review and meta-analysis", Int J Public Health, 65, pp.533~546 (2020)
- Burian E, "Intensive care risk estimation in COVID-19 pneumonia based on clinical and imaging parameters : experiences from the Munich Cohort", J Clin Med, 9, pp.1514~ (2020)
- Bertelli M, "COVID-19 ARDS is characterized by increased dead space ventilation compared with non-COVID ARDS", Respir Care, 66, pp.1406~1415 (2021)
- Li X, "Acute respiratory failure in COVID-19 : is it"typical"ARDS?", Crit Care, 24, pp.198~ (2020)
- 조영재, "Clinical Practice Guideline of Acute Respiratory Distress Syndrome", Acute and Critical Care, 31(2), pp.76~100 (2016), 대한중환자의학회
- Alhazzani W, "Surviving sepsis campaign : guidelines on the management of critically ill adults with Coronavirus Disease 2019(COVID-19)", Intensive Care Med, 46, pp.854~887 (2020)
- Zawaydeh Q, "The effect of steroid dosing on risk of secondary infection in COVID-19 critically ill patients. TP091 epidemiology and translational advances in SARS-COV-2", Am J Respir Crit Care Med, 203, pp.A3806~ (2021)
- Huang E, "Tocilizumab for Covid-19 : the ongoing search for effective therapies", N Engl J Med, 383, pp.2387~2388 (2020)
- Vlachos S, "Hospital mortality and resource implications of hospitalisation with COVID-19 in London, UK : a prospective cohort study", Crit Care Res Pract, 2021, pp.8832660~ (2021)
- 강승지, "Age-Related Morbidity and Mortality among Patients with COVID-19", Infection and Chemotherapy, 52(2), pp.154~164 (2020), 대한감염학회[DOI]
- Reddy RK, "The effect of smoking on COVID-19 severity : a systematic review and meta-analysis", J Med Virol, 93, pp.1045~1056 (2021)
- Beigmohammadi MT, "Mortality predictive value of APACHE II and SOFA scores in COVID-19 patients in the intensive care unit", Can Respir J, 2022, pp.5129314~ (2022)
- Tapaskar N, "Sedation usage in COVID-19 acute respiratory distress syndrome : a multicenter study", Ann Pharmacother, 56, pp.117~123 (2022)
- Lee BY, "Lower driving pressure and neuromuscular blocker use are associated with decreased mortality in patients with COVID-19 ARDS", Respiratory Care, 67, pp.216~226 (2022)
- Yang AP, "The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients", Int Immunopharmacol, 84, pp.106504~ (2020)
- Shang W, "The value of clinical parameters in predicting the severity of COVID-19", J Med Virol, 92, pp.2188~2192 (2020)
- Prediletto I, "Standardizing PaO2 for PaCO2 in P", F ratio predicts in-hospital mortality in acute respiratory failure due to Covid-19 : a pilot prospective study, 2021, pp.92, 48~54
- Rostami M, "D-dimer level in COVID-19 infection : a systematic review", Expert Rev Hematol, 13, pp.1265~1275 (2020)
- Iba T, "The unique characteristics of COVID-19 coagulopathy", Crit Care, 24, pp.360~ (2020)